Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

2017 IPOs In Review: US Biopharma Offerings Rise, Values Decline At Mid-Year

Jul 13 2017

• By Mandy Jackson

stock

Related Content

Finance Watch: Two New VC Funds Raise $500m; One New US IPO; And Galena's 'Strategic Review'

Mar 17 2017

Finance Watch: Two More US Biopharma IPOs And Two New European VC Funds

May 20 2017

US IPOs In Review: Relatively Muted Market In 2016 To Continue In 2017

Dec 31 2016

After Tocagen Thaws IPO Freeze, Verona And Zymeworks Bring April Total To Three

Apr 29 2017

IPO Update: Three Biopharma Offerings In January Contrast With Last Year’s Slow Start

Feb 06 2017

Biopharma IPOs Gain Momentum As Three More Launch In The US

May 10 2017

Related Companies

BeyondSpring Inc.

ObsEva SA

Tocagen, Inc.

AnaptysBio, Inc.

Jounce Therapeutics, Inc.

ObsEva SA

BeyondSpring Inc.

Tocagen, Inc.

Verona Pharma plc

Zymeworks, Inc.

Ovid Therapeutics, Inc.

UroGen Pharma, Ltd.

Biohaven Pharmaceutical Holding Company Ltd.

G1 Therapeutics Inc.

argenx N.V.

Athenex, Inc.

Immuron Ltd.

Dova Pharmaceuticals, Inc.

Mersana Therapeutics, Inc.

Rein Therapeutics, Inc.

Fortress Biotech Inc.

Additional Topics

Commercial Financing Business Strategies BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window